Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Polymerase chain reaction-based diagnosis of del (5q) in acute myeloid leukemia and myelodysplastic syndrome identifies a minimal deletion interval

SK Horrigan, CA Westbrook, AH Kim, M Banerjee, W Stock, RA Larson

Blood (1996) 88 (7): 2665–2670.

https://doi.org/10.1182/blood.V88.7.2665.bloodjournal8872665

Published: 1996

Journal Articles

Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases

MM Beau, R 3rd Espinosa, EM Davis, JD Eisenbart, RA Larson, ED Green

Blood (1996) 88 (6): 1930–1935.

https://doi.org/10.1182/blood.V88.6.1930.bloodjournal8861930

Published: 1996

Journal Articles

Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia with fludarabine [letter]

ST Ong, H Koeppen, RA Larson, OI Olopade

Blood (1996) 88 (6): 2354–2355.

https://doi.org/10.1182/blood.V88.6.2354.bloodjournal8862354

Published: 1996

Journal Articles

A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811

RA Larson, RK Dodge, CP Burns, EJ Lee, RM Stone, P Schulman, D Duggan, FR Davey, RE Sobol, SR Frankel

Blood (1995) 85 (8): 2025–2037.

https://doi.org/10.1182/blood.V85.8.2025.bloodjournal8582025

Published: 1995

Journal Articles

Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA- topoisomerase II

HJ Super, NR McCabe, MJ Thirman, RA Larson, MM Le Beau, J Pedersen-Bjergaard, P Philip, MO Diaz, JD Rowley

Blood (1993) 82 (12): 3705–3711.

https://doi.org/10.1182/blood.V82.12.3705.3705

Published: 1993

Journal Articles

Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission

G Nucifora, RA Larson, JD Rowley

Blood (1993) 82 (3): 712–715.

https://doi.org/10.1182/blood.V82.3.712.712

Published: 1993

Journal Articles

Cytogenetic clonality in myelodysplastic syndromes studied with fluorescence in situ hybridization: lineage, response to growth factor therapy, and clone expansion

J Anastasi, J Feng, MM Le Beau, RA Larson, JD Rowley, JW Vardiman

Blood (1993) 81 (6): 1580–1585.

https://doi.org/10.1182/blood.V81.6.1580.1580

Published: 1993

Journal Articles

Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762)

CA Westbrook, AL Hooberman, C Spino, RK Dodge, RA Larson, F Davey, DH Wurster- Hill, RE Sobol, C Schiffer, CD Bloomfield

Blood (1992) 80 (12): 2983–2990.

https://doi.org/10.1182/blood.V80.12.2983.2983

Published: 1992

Journal Articles

Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia

OI Olopade, M Thangavelu, RA Larson, R Mick, A Kowal-Vern, HR Schumacher, MM Le Beau, JW Vardiman, JD Rowley

Blood (1992) 80 (11): 2873–2882.

https://doi.org/10.1182/blood.V80.11.2873.2873

Published: 1992

Journal Articles

Clinical and cytogenetic responses to granulocyte-macrophage colony- stimulating factor in therapy-related myelodysplasia

WJ Gradishar, MM Le Beau, R O'Laughlin, JW Vardiman, RA Larson

Blood (1992) 80 (10): 2463–2470.

https://doi.org/10.1182/blood.V80.10.2463.2463

Published: 1992

Journal Articles

Alteration of the proliferative rate of acute myelogenous leukemia cells in vivo in patients

HD Preisler, A Raza, RA Larson

Blood (1992) 80 (10): 2600–2603.

https://doi.org/10.1182/blood.V80.10.2600.2600

Published: 1992

Journal Articles

Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridization to interphase cells: a simple and sensitive method

J Anastasi, MM Le Beau, JW Vardiman, AA Fernald, RA Larson, JD Rowley

Blood (1992) 79 (7): 1796–1801.

https://doi.org/10.1182/blood.V79.7.1796.1796

Published: 1992

Journal Articles

Balanced translocations involving chromosome bands 11q23 and 21q22 in therapy-related leukemia [letter]

RA Larson, MM Le Beau, MJ Ratain, JD Rowley

Blood (1992) 79 (7): 1892–1893.

https://doi.org/10.1182/blood.V79.7.1892.1892

Published: 1992

Journal Articles

Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disorders

WL Neuman, CM Rubin, RB Rios, RA Larson, MM Le Beau, JD Rowley, JW Vardiman, JL Schwartz, RA Farber

Blood (1992) 79 (6): 1501–1510.

https://doi.org/10.1182/blood.V79.6.1501.1501

Published: 1992

Journal Articles

Trisomy 6: a recurring cytogenetic abnormality associated with marrow hypoplasia [letter]

JA Moormeier, CM Rubin, MM Le Beau, JW Vardiman, RA Larson, JN Winter

Blood (1991) 77 (6): 1397–1398.

https://doi.org/10.1182/blood.V77.6.1397.1397

Published: 1991

Journal Articles

Inhibition of hydroxymethylglutaryl coenzyme A reductase activity induces a paradoxical increase in DNA synthesis in myeloid leukemia cells

RJ Hohl, RA Larson, V Mannickarottu, S Yachnin

Blood (1991) 77 (5): 1064–1070.

https://doi.org/10.1182/blood.V77.5.1064.1064

Published: 1991

Journal Articles

Interphase cytogenetic analysis detects minimal residual disease in a case of acute lymphoblastic leukemia and resolves the question of origin of relapse after allogeneic bone marrow transplantation

J Anastasi, M Thangavelu, JW Vardiman, AL Hooberman, ML Bian, RA Larson, MM Le Beau

Blood (1991) 77 (5): 1087–1091.

https://doi.org/10.1182/blood.V77.5.1087.1087

Published: 1991

Journal Articles

t(3;21)(q26;q22): a recurring chromosomal abnormality in therapy- related myelodysplastic syndrome and acute myeloid leukemia

CM Rubin, RA Larson, J Anastasi, JN Winter, M Thangavelu, JW Vardiman, JD Rowley, MM Le Beau

Blood (1990) 76 (12): 2594–2598.

https://doi.org/10.1182/blood.V76.12.2594.2594

Published: 1990

Journal Articles

Interleukin-4 and interleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del(5q)

MM Le Beau, RS Lemons, R 3d Espinosa, RA Larson, N Arai, JD Rowley

Blood (1989) 73 (3): 647–650.

https://doi.org/10.1182/blood.V73.3.647.647

Published: 1989

Journal Articles

Short remission durations in therapy-related leukemia despite cytogenetic complete responses to high-dose cytarabine

RA Larson, M Wernli, MM Le Beau, KM Daly, LH Pape, JD Rowley, JW Vardiman

Blood (1988) 72 (4): 1333–1339.

https://doi.org/10.1182/blood.V72.4.1333.1333

Published: 1988

NARROW

Polymerase chain reaction-based diagnosis of del (5q) in acute myeloid leukemia and myelodysplastic syndrome identifies a minimal deletion interval

Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases

Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia with fludarabine [letter]

A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811

Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA- topoisomerase II

Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission

Cytogenetic clonality in myelodysplastic syndromes studied with fluorescence in situ hybridization: lineage, response to growth factor therapy, and clone expansion

Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762)

Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia

Clinical and cytogenetic responses to granulocyte-macrophage colony- stimulating factor in therapy-related myelodysplasia

Alteration of the proliferative rate of acute myelogenous leukemia cells in vivo in patients

Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridization to interphase cells: a simple and sensitive method

Balanced translocations involving chromosome bands 11q23 and 21q22 in therapy-related leukemia [letter]

Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disorders

Trisomy 6: a recurring cytogenetic abnormality associated with marrow hypoplasia [letter]

Inhibition of hydroxymethylglutaryl coenzyme A reductase activity induces a paradoxical increase in DNA synthesis in myeloid leukemia cells

Interphase cytogenetic analysis detects minimal residual disease in a case of acute lymphoblastic leukemia and resolves the question of origin of relapse after allogeneic bone marrow transplantation

t(3;21)(q26;q22): a recurring chromosomal abnormality in therapy- related myelodysplastic syndrome and acute myeloid leukemia

Interleukin-4 and interleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del(5q)

Short remission durations in therapy-related leukemia despite cytogenetic complete responses to high-dose cytarabine

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only